Hans-Michael Kvasnicka

6PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeonatologyImmunogenetics (incl. genetic immunology)Predictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 29, 2022
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms.

Umberto Gianelli, Jürgen Thiele, Attilio Orazi

|Jul 12, 2022
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.

R J Leguit, A Orazi, N Kucine

|Jul 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responses.

Martin Frejno, Chen Meng, Benjamin Ruprecht

|Mar 17, 2018
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.

Hans Michael Kvasnicka, Jürgen Thiele, Carlos E Bueso-Ramos

Pageof 1